Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-06-26 @ 4:38 AM
Study NCT ID:
NCT00217594
Status:
COMPLETED
Last Update Posted:
2018-10-30
First Post:
2005-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
050206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None